Aquestive sheds a third after receiving FDA response for Libervant application

seekingalpha2021-12-21

Aquestive Therapeutics drops nearly 30% premarket after receiving FDA notification regarding the review of the New Drug Application (NDA) for Libervant (diazepam) Buccal Film for the treatment of ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

BKT
2021-12-21
BKT
Good. Pls like thanks.
Dsd
2021-12-21
Dsd
...
boonwt
2021-12-21
boonwt
Hmm
- RaymondLim:
  ok
NPC69
2021-12-21
NPC69
K
- RaymondLim:
  ok
- jingabel:
  ok
LY1970
2021-12-21
LY1970
Hello
- Dsd:
  ...
- LY1970:
  Bj
auahau
2021-12-21
auahau
wow
- thatsy:
  Paper hands

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1180762572?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-12-21 19:31","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"1180762572","market":"us","top_or_hot":-1,"title":"Aquestive sheds a third after receiving FDA response for Libervant application","media":"seekingalpha","content":"<div>\n<p>Aquestive Therapeutics drops nearly 30% premarket after receiving FDA notification regarding the review of the New Drug Application (NDA) for Libervant (diazepam) Buccal Film for the treatment of ...</p>\n\n<a href=\"https://seekingalpha.com/news/3782227-aquestive-sheds-a-third-after-receiving-fda-response-for-libervant-application\">网页链接</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Aquestive sheds a third after receiving FDA response for Libervant application</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAquestive sheds a third after receiving FDA response for Libervant application\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-21 19:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3782227-aquestive-sheds-a-third-after-receiving-fda-response-for-libervant-application><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Aquestive Therapeutics drops nearly 30% premarket after receiving FDA notification regarding the review of the New Drug Application (NDA) for Libervant (diazepam) Buccal Film for the treatment of ...</p>\n\n<a href=\"https://seekingalpha.com/news/3782227-aquestive-sheds-a-third-after-receiving-fda-response-for-libervant-application\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AQST","symbol_name":"Aquestive Therapeutics Inc.","start_time":0,"source_url":"https://seekingalpha.com/news/3782227-aquestive-sheds-a-third-after-receiving-fda-response-for-libervant-application","article_id":"1180762572","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1180762572","pubTimestamp":1640086307,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"Aquestive Therapeutics drops nearly 30% premarket after receiving FDA notification regarding the rev","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"AQST":"Aquestive Therapeutics Inc."},"translate_title":"在收到FDA对Libervant申请的回应后，Aquestive脱落了三分之一","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AQST":0.9},"content_text":"Aquestive Therapeutics drops nearly 30% premarket after receiving FDA notification regarding the review of the New Drug Application (NDA) for Libervant (diazepam) Buccal Film for the treatment of breakthrough seizures and seizure clusters.\nThe notice stated, \"the Agency is still considering the regulatory issues related to the approvability of Libervant, and will not be ready to take an action by December 23, 2021. No additional information is needed from you at this time. We are currently unable to provide an estimate of the timing of an expected action; however, we will provide any updates we can as they are available.”\nThe company is currently reaching out to the FDA to seek further clarity.\nIn July 2021, the FDA accepted the NDA for Libervant and assigned a PDUFA target goal date of December 23, 2021.\nThe Company continues to advance AQST-109 as it began the EPIPHAST study, with results expected in H1 2022.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":691046894,"gmtCreate":1640102331922,"gmtModify":1640102332112,"author":{"id":"3570853427202414","authorId":"3570853427202414","name":"BKT","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3570853427202414","authorIdStr":"3570853427202414"},"htmlText":"Good. Pls like thanks.","listText":"Good. Pls like thanks.","text":"Good. Pls like thanks.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691046894","repostId":1180762572,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":693747941,"gmtCreate":1640089925284,"gmtModify":1640089925439,"author":{"id":"3581036261146444","authorId":"3581036261146444","name":"Dsd","avatar":"https://static.tigerbbs.com/2a1957746498df0232ae53ac81018443","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3581036261146444","authorIdStr":"3581036261146444"},"htmlText":"...","listText":"...","text":"...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/693747941","repostId":1180762572,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":693746556,"gmtCreate":1640089100605,"gmtModify":1640089100704,"author":{"id":"3582940622326289","authorId":"3582940622326289","name":"boonwt","avatar":"https://static.tigerbbs.com/e4d5c6d9b0cc6a1498dd442e0259cd8a","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3582940622326289","authorIdStr":"3582940622326289"},"htmlText":"Hmm","listText":"Hmm","text":"Hmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/693746556","repostId":1180762572,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":7066516,"gmtCreate":1640090768655,"gmtModify":1640090768712,"authorId":3581634125853828,"author":{"id":3581634125853828,"idStr":"3581634125853828","authorId":3581634125853828,"name":"RaymondLim","avatar":"https://static.tigerbbs.com/d3081d4d67e2198188bc8039305c484f","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":693746556,"type":1,"supId":0,"prevId":0,"content":"ok","text":"ok","html":"ok"}],"langContent":"CN"},{"id":693743161,"gmtCreate":1640088406990,"gmtModify":1640088407470,"author":{"id":"3584779133668268","authorId":"3584779133668268","name":"NPC69","avatar":"https://static.tigerbbs.com/47e7ac55312ae8dd1c9e7cb92adad089","vip":1,"crmLevel":6,"crmLevelSwitch":0,"idStr":"3584779133668268","authorIdStr":"3584779133668268"},"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/693743161","repostId":1180762572,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":7066515,"gmtCreate":1640090760919,"gmtModify":1640090761018,"authorId":3581634125853828,"author":{"id":3581634125853828,"idStr":"3581634125853828","authorId":3581634125853828,"name":"RaymondLim","avatar":"https://static.tigerbbs.com/d3081d4d67e2198188bc8039305c484f","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":693743161,"type":1,"supId":0,"prevId":0,"content":"<u>ok</u>","text":"<u>ok</u>","html":"<u>ok</u>"},{"id":7066409,"gmtCreate":1640089535076,"gmtModify":1640089535110,"authorId":3579683280519440,"author":{"id":3579683280519440,"idStr":"3579683280519440","authorId":3579683280519440,"name":"jingabel","avatar":"https://static.tigerbbs.com/5109716c64f0b691a5098e4d5397ffc2","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":693743161,"type":1,"supId":0,"prevId":0,"content":"ok","text":"ok","html":"ok"}],"langContent":"CN"},{"id":693749480,"gmtCreate":1640088381052,"gmtModify":1640088381329,"author":{"id":"3581643786644012","authorId":"3581643786644012","name":"LY1970","avatar":"https://static.tigerbbs.com/99deb9932439b87c6072806b53ff4f0b","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3581643786644012","authorIdStr":"3581643786644012"},"htmlText":"Hello","listText":"Hello","text":"Hello","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/693749480","repostId":1180762572,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":7066436,"gmtCreate":1640089939878,"gmtModify":1640089939977,"authorId":3581036261146444,"author":{"id":3581036261146444,"idStr":"3581036261146444","authorId":3581036261146444,"name":"Dsd","avatar":"https://static.tigerbbs.com/2a1957746498df0232ae53ac81018443","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":693749480,"type":1,"supId":0,"prevId":0,"content":"...","text":"...","html":"..."},{"id":7066309,"gmtCreate":1640088386792,"gmtModify":1640088386881,"authorId":3581643786644012,"author":{"id":3581643786644012,"idStr":"3581643786644012","authorId":3581643786644012,"name":"LY1970","avatar":"https://static.tigerbbs.com/99deb9932439b87c6072806b53ff4f0b","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":693749480,"type":1,"supId":0,"prevId":0,"content":"Bj","text":"Bj","html":"Bj"}],"langContent":"CN"},{"id":693749815,"gmtCreate":1640088326944,"gmtModify":1640088327196,"author":{"id":"3575098313311401","authorId":"3575098313311401","name":"auahau","avatar":"https://static.tigerbbs.com/51a7e0e9a14e5faa1ff39d0755eb5e92","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3575098313311401","authorIdStr":"3575098313311401"},"htmlText":"wow","listText":"wow","text":"wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/693749815","repostId":1180762572,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":7066307,"gmtCreate":1640088377846,"gmtModify":1640088377882,"authorId":3553846715363515,"author":{"id":3553846715363515,"idStr":"3553846715363515","authorId":3553846715363515,"name":"thatsy","avatar":"https://static.tigerbbs.com/f26fbbdbb8bc4a4041112e5874d1041e","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":693749815,"type":1,"supId":0,"prevId":0,"content":"Paper hands","text":"Paper hands","html":"Paper hands"}],"langContent":"CN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":86,"commentSize":12,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1180762572"}